Mentari Therapeutics' total liabilities rise to $78.61 million from $10.26 million at year-end
MTRI•Mentari Therapeutics reported total liabilities of $78.61 million at September 30, 2026, up from $10.26 million at December 31, 2025. Cash and cash equivalents were $45.79 million, down from $46.26 million.




